TEVA (Teva Pharmaceutical-Sp ) Technical Analysis

TEVA Technical Analysis leverages historical price and volume data to provide real-time indicator values and signals, including RSI, MACD, Bollinger Bands, and volume, to reflect market momentum, volatility ranges, and price-volume dynamics. It also integrates market sentiment metrics such as the VIX volatility index, Advance-Decline ratio (A/D ratio), and Put/Call options ratio for broader market context. Multi-timeframe views span from minute intervals to daily, weekly, and monthly charts, making it easy to track indicator behavior across periods. Key support and resistance levels are displayed alongside current prices, calculated via pivots, Fibonacci retracements, and historical extremes to offer an immediate overview of market structure.
TEVA
TEVA

Teva Pharmaceutical-Sp

$33.56-1.00%
Today's High$34.04
Today's Low$33.23
Today's Open$33.68
Yesterday's Close$33.90

TEVA (Teva Pharmaceutical-Sp ) Technical Analysis Overview

AI CreationAs of June 30, 2026, Teva Pharmaceutical (TEVA) is showing mixed technical signals with a neutral-to-range-bound bias. The MACD Level at -0.1183 carries a buy signal suggesting momentum remains constructive, while the RSI(14) at 53.3526 occupies neutral territory, indicating balanced buying and selling pressure with neither bulls nor bears in clear control. The ADX(14) reading of 10.4674 reveals weak trend strength below 20, implying the stock is more prone to consolidation than decisive directional movement. The moving average system exhibits broad alignment with buy signals across EMA10 (33.479), EMA20 (33.569), EMA50 (33.4205), and SMA200 (29.2541), though the weak ADX and neutral RSI suggest that conviction behind the upside remains limited, typical of a stock in early recovery within a consolidation phase.

Oscillators

Strong Sell
Strong Buy
Buy
0
Sell
8
Neutral
3
Buy

Summary

Strong Sell
Strong Buy
Buy
3
Sell
9
Neutral
14
Buy

Moving Averages

Strong Sell
Strong Buy
Strong Buy
3
Sell
1
Neutral
11
Buy

TEVA (Teva Pharmaceutical-Sp ) Live Candlestick Chart

TEVA (Teva Pharmaceutical-Sp ) Multi-Timeframe Technical Rating

Summary1H4H1D1W
Moving Averages (15)104122113131
Oscillators (11)NeutralNeutralNeutralNeutral
RSI (14)51.252.350.756.4
MACD (12,26)Golden CrossGolden CrossDeath CrossGolden Cross

TEVA (Teva Pharmaceutical-Sp ) Technical Indicator Interpretation

Based on 1-day closing price series

Oscillators

NameValueOperation
RSI(14)
50.7194Neutral
Stochastic %K (14, 3, 3)
63.633Neutral
Commodity Channel Index (CCI) (20)
20.301Neutral
Average Directional Index (ADX) (14)
10.4702Neutral
Awesome Oscillator (AO)
-0.2796Neutral
Momentum Indicator (10)
0.795Buy
MACD Level (12, 26)
-0.1105Buy
Stochastic RSI Fast (3, 3, 14, 14)
80.8601Neutral
Williams Percent Range (%R) (14)
-34.7191Neutral
Bull Bear Power (BBP)
0.3676Buy
Ultimate Oscillator (UO) (7, 14, 28)
53.4419Neutral

Moving Averages

NameValueOperation
EMA (10)
33.4755Buy
SMA (10)
33.1395Buy
EMA (20)
33.5561Buy
SMA (20)
33.4962Buy
EMA (30)
33.5906Buy
SMA (30)
33.7758Sell
EMA (50)
33.4203Buy
SMA (50)
33.9347Sell
EMA (100)
32.3726Buy
SMA (100)
32.7542Buy
EMA (200)
29.5158Buy
SMA (200)
29.3215Buy
Ichimoku Kinko Hyo Base Line (9, 26, 52, 26)
33.135Neutral
Volume-Weighted Moving Average (VWMA) (20)
33.4134Buy
Hull Moving Average (HMA) (9)
33.7369Sell

TEVA (Teva Pharmaceutical-Sp ) Pivot Points

Based on 1-day timeframe

PriceClassicFibonacciCamarillaWoodieDM
R342.2137.7635.103840.505-
R237.7636.060134.695837.8775-
R135.8235.009934.287936.05534.565
Pivot P33.3133.3133.3133.427532.6825
S131.3731.610133.472131.60530.115
S228.8630.559933.064228.9775-
S324.4128.8632.656327.155-

TEVA (Teva Pharmaceutical-Sp ) Market Sentiment Index

Analyst Rating40.9
Options Put/Call Ratio+13.10%
Implied Volatility (IV)27.5113

TEVA (Teva Pharmaceutical-Sp ) Deep Technical Analysis

As of June 30, 2026, TEVA is exhibiting a range-bound technical structure with mixed directional signals. The MACD Level at -0.1183 carries a buy signal, implying momentum remains intact despite modest weakness; the RSI(14) at 53.3526 sits squarely in the neutral zone (45–55 range), confirming that neither bulls nor bears have established dominance and buying and selling forces remain balanced. **TEVA technical analysis** reveals that the Momentum(10) indicator at 0.49 reinforces the buy signal, suggesting underlying buying pressure, though the modest positive reading lacks strong conviction for a decisive bullish move. The ADX(14) reading of 10.4674 carries a neutral signal, placing trend strength in the weak category (below 20), which implies that directional persistence is limited and price action is more prone to consolidation and choppy oscillation rather than a sustained advance or decline. The Commodity Channel Index (20) at 36.0003 also registers as neutral, reflecting the absence of extreme overbought or oversold conditions; combined with the weak ADX, this pattern reinforces the view that sideways movement is the path of least resistance for the near term. EMA10 at 33.479, EMA20 at 33.569, EMA50 at 33.4205, and SMA20 at 33.48 all issue buy signals, while the longer-duration moving averages—EMA100 at 32.3516, EMA200 at 29.4767, and SMA200 at 29.2541—also flash buy signals, indicating that both short-term and medium-to-long-term trends remain supportive. This convergence means the **TEVA price forecast** is anchored by structural support across multiple timeframes, though the weak ADX suggests that buyers have not yet overwhelmed sellers decisively. resistance targets lie at R1 (36.5978), R2 (37.3955), and R3 (38.6867), while support zones are anchored at S1 (34.0155), S2 (33.2178), and S3 (31.9267). The current price of 33.84 sits between S1 and the pivot, suggesting the stock is testing intermediate support; a sustained hold above SMA20 (33.48) would signal renewed short-term buying interest, whereas a break below S2 (33.2178) would confirm further weakness toward S3. The implied volatility at 27.5113 indicates moderate-to-elevated price swings are expected, useful context for setting stop-loss distances around the S2 and S3 zone. On the market breadth front, the option put-call ratio of 13.1 signals moderate hedging demand, suggesting traders maintain a balanced defensive posture without extreme risk aversion. The analyst rating of 40.9 remains moderately positive, indicating that fundamental analysts retain a constructive view despite near-term technical consolidation. This alignment between technicians (showing buy signals with weak trend strength) and analysts (leaning positive) reinforces the neutral-to-constructive consensus; the near-term **TEVA market analysis** suggests a wait-and-see posture until the stock either breaks above R1 (36.5978) to confirm renewed conviction or breaks below S2 (33.2178) to signal deeper weakness.

FAQ

What is the current technical rating for TEVA?

x
On the 4H timeframe, the aggregate technical rating for TEVA is Buy. This rating is dynamically aggregated from moving averages and momentum oscillators to reflect the prevailing trend direction and price velocity.

Where are the key support and resistance levels for TEVA?

x

What are the current RSI and MACD signals for TEVA?

x

How often is the TEVA technical analysis data updated?

x

Continue Exploring TEVA (Teva Pharmaceutical-Sp )

Risk Warning:

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Warning.

Disclaimer:

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.